HYB.F HOYA Corporation
- Market cap
- EUR 44.6B
- P/E
- 29.3x
- P/B
- 7.75x
- ROE
- 27.0%
- Dividend yield
- 1.36%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is HYB.F undervalued?
Graham numberThe Graham number of HOYA Corporation cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
HOYA Corporation fundamental analysis
No fundamental analysis for HOYA Corporation yet.
HOYA Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About HOYA Corporation
HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asia, the Americas, Europe, and internationally. The company operates through two segments: Life Care, and Information and Communications. It offers life care products, including eyeglasses; contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fi…
Full company profileHOYA Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
HOYA Corporation annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 490B | 541B | 572B | 582B | 208B | 670B | 734B | 793B | 886B | 996B | 1.04T |
| Gross Profit | 412B | 457B | 488B | 488B | 101B | 567B | 632B | 688B | 766B | 860B | 897B |
| Operating Income | 222B | 250B | 278B | 269B | 44.3B | 363B | 401B | 433B | 481B | 551B | 407B |
| EBITDA | - | 154B | 171B | 182B | 162B | 255B | 267B | 286B | 310B | 388B | 422B |
| Net Income | 86.7B | 99.5B | 122B | 114B | 107B | 165B | 169B | 181B | 202B | 253B | 273B |
| EPS | 224 | 262 | 321 | 305 | 290 | 451 | 476 | 517 | 590 | 754 | 821 |
| Balance Sheet | |||||||||||
| Total Assets | 660B | 651B | 764B | 811B | 853B | 993B | 1.03T | 1.20T | 1.23T | 1.30T | 1.30T |
| Total Liabilities | 144B | 120B | 136B | 182B | 181B | 204B | 214B | 241B | 263B | 266B | 274B |
| Shareholders' Equity | 511B | 526B | 623B | 645B | 688B | 804B | 818B | 968B | 974B | 1.02T | 1.01T |
| Cash & Short-term Investments | 297B | 246B | 293B | 318B | 335B | 419B | 406B | 525B | 534B | 574B | 562B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 108B | 135B | 147B | 163B | 152B | 190B | 202B | 223B | 235B | 278B | 316B |
| Capital Expenditure | 21.5B | 18.0B | 26.7B | 45.2B | 31.2B | 28.9B | 33.5B | 41.1B | 47.9B | 56.6B | 57.5B |
| Free Cash Flow | - | 118B | 120B | 118B | 121B | 161B | 168B | 182B | 187B | 222B | 259B |
| Ratios | |||||||||||
| ROE | 17.0% | 18.9% | 19.6% | 17.7% | 15.6% | 20.5% | 20.6% | 18.7% | 20.7% | 24.8% | 27.0% |
| ROA | 13.2% | 15.3% | 16.0% | 14.1% | 12.6% | 16.6% | 16.4% | 15.1% | 16.4% | 19.5% | 21.0% |
| Net Profit Margin | 17.7% | 18.4% | 21.3% | 19.6% | 51.6% | 24.5% | 23.0% | 22.9% | 22.8% | 25.4% | 26.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
HOYA Corporation dividends
- Dividend yield
- 1.36%
- Forward dividend
- 1.82 EUR
- Payout ratio
- 32.4%
- Ex-dividend date
- Sep 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 81.9B | 244 | 32.4% |
| 2025 | JPY 38.4B | 112 | 19.0% |
| 2024 | JPY 38.8B | 111 | 21.4% |
| 2023 | JPY 39.8B | 112 | 23.6% |
| 2022 | JPY 33.2B | 91 | 20.2% |
| 2021 | JPY 33.7B | 91 | 31.4% |
| 2020 | JPY 34.0B | 91 | 29.8% |
| 2019 | JPY 34.1B | 90 | 28.0% |
| 2018 | JPY 29.0B | 77 | 29.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 4:1 on Sep 27, 2005.
Who owns HOYA Corporation
- Insiders 1.28%
- Institutions 59.44%
- Public & others 39.28%
- Shares outstanding 332M
- Free float 330M
HOYA Corporation company profile
- Company name
- HOYA Corporation
- Ticker
- HYB.F
- ISIN
- JP3837800006
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 37,752
- Fiscal year end
- March
- Address
- Nittochi Nishishinjuku Building, Shinjuku, Japan, 160-8347
- Phone
- 81 3 6911 4811
- Website
- hoya.com
About HOYA Corporation
HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asia, the Americas, Europe, and internationally. The company operates through two segments: Life Care, and Information and Communications. It offers life care products, including eyeglasses; contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics, brain surgery, and dentistry. The company also operates Eyecity, a specialty retailer of contact lenses. In addition, it provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; glass disks for hard disk drives; and imaging related products that comprise optical glasses/optical lenses, colored glass filters, and UV light resources. Further, the company engages in research, development, manufacture, and sale of photomasks for manufacturing flat panel displays. HOYA Corporation was founded in 1941 and is headquartered in Shinjuku, Japan.
HOYA Corporation management
4- Mr. Eiichiro IkedaRepresentative Executive Officer, President, CEO & Chairperson of Board of Directors · born 1970
- Mr. Ryo HirookaRepresentative Executive Officer, CFO & Director · born 1974
- Ms. Tomoko NakagawaExecutive Officer & Chief Sustainability (ESG) Officer · born 1960
- Mr. Taishi ArashidaOfficer of IR